Report overview
The Oncology Drug Discovery Service is dedicated to oncology research, providing high-quality, timely and cost-effective oncology drug discovery and accelerating the development of the immunooncology product portfolio to develop new drugs that benefit human health.
This report aims to provide a comprehensive presentation of the global market for Oncology Drug Discovery Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Drug Discovery Services. This report contains market size and forecasts of Oncology Drug Discovery Services in global, including the following market information:
Global Oncology Drug Discovery Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Oncology Drug Discovery Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Identification Service Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oncology Drug Discovery Services include Charles River, Evotec, GE Healthcare Life Sciences, GenScript, Horizon Discovery, TCG Lifesciences, Zumutor, ChemPartner and Aquila BioMedical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oncology Drug Discovery Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Drug Discovery Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Oncology Drug Discovery Services Market Segment Percentages, by Type, 2022 (%)
Identification Service
Authentication Service
Hit-to-lead and Lead Optimization Services
Others
Global Oncology Drug Discovery Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Oncology Drug Discovery Services Market Segment Percentages, by Application, 2022 (%)
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
Global Oncology Drug Discovery Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Oncology Drug Discovery Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Drug Discovery Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oncology Drug Discovery Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Charles River
Evotec
GE Healthcare Life Sciences
GenScript
Horizon Discovery
TCG Lifesciences
Zumutor
ChemPartner
Aquila BioMedical
Onconova
Vichem Chemie
GVK Biosciences
NuChem Therapeutics
Syncom
Envigo
DiverChim
Aurora
HD Biosciences
WuXi AppTec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology Drug Discovery Services, market overview.
Chapter 2: Global Oncology Drug Discovery Services market size in revenue.
Chapter 3: Detailed analysis of Oncology Drug Discovery Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology Drug Discovery Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
